THE HARVARD DRUG GROUP, L.L.C.
Federal contract awards won by THE HARVARD DRUG GROUP, L.L.C. (UEI CBGGKKVNJBK9), 2022–2025 — public record from USAspending.
Showing awards of $250K+ active within the last 5 years. Need older history or smaller awards? Tell us what you need — we expand by request.
4
awards
$496,021,404
total value
1
agency
Agencies buying from THE HARVARD DRUG GROUP, L.L.C.
What THE HARVARD DRUG GROUP, L.L.C. sells
Awards
65 I B, DRUGS, PHARMACEUTICALS, & HEMATOLOGY RELATED PRODUCTS, FSS CONTRACT AWARD
Department of Veterans Affairs · $420,103,330 · Jun 1, 2025
NEW AWARD FOR BUPROPION TABLETS WITH MAJOR. PERIOD OF PERFORMANCE IS 3/1/2025-2/28/2026 WITH FOUR ONE-YEAR OPTIONS
Department of Veterans Affairs · $2,936,792 · Mar 1, 2025
NEW AWARD FOR LURASIDONE HCL TABLETS WITH THE HARVARD DRUG GROUP, L.L.C. DBA MAJOR PHARMACEUTICALS. BASE YEAR ORDERING PERIOD IS 12/10/2024 TO 12/09/2025 WITH FOUR ONE-YEAR OPTIONS.
Department of Veterans Affairs · $10,056,938 · Dec 10, 2024
NEW AWARD FOR TAMSULOSIN CAPSULES WITH THE HARVARD DRUG GROUP, L.L.C. DBA MAJOR PHARMACEUTICALS AND RUGBY LABORATORIES. PERIOD OF PERFORMANCE IS JUN 1, 2022 TO MAY 31, 2023 WITH FOUR ONE-YEAR OPTIONS.
Department of Veterans Affairs · $62,924,344 · Jun 1, 2022
Researching this competitor? BidCatch doesn't just show you what they won — it sends you the open bids in your trade every morning, before they're awarded. Free for 14 days, then $49.99/month.
Search open bids